Novo Nordisk Long Term Debt 2012-2026 | NVO

Novo Nordisk long term debt for the quarter ending March 31, 2026 was $18.662B, a 37.33% increase year-over-year.

  • Novo Nordisk long term debt for 2025 was $18.008B, a 38.49% increase from 2024.
  • Novo Nordisk long term debt for 2024 was $13.003B, a 336.24% increase from 2023.
  • Novo Nordisk long term debt for 2023 was $2.981B, a 13.44% decline from 2022.

Novo Nordisk Long Term Debt 2012-2026 | NVO

  • Novo Nordisk long term debt for 2025 was $18.008B, a 38.49% increase from 2024.
  • Novo Nordisk long term debt for 2024 was $13.003B, a 336.24% increase from 2023.
  • Novo Nordisk long term debt for 2023 was $2.981B, a 13.44% decline from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B